Open Access
Research (Published online: 29-09-2022)
27. Effectiveness of Indonesian house dust mite allergenic extract in triggering allergic rhinitis sensitivity in a mouse model: A preliminary study
Yusuf Alif Pratama, Fakhriyah Dinina, Ahmad Dzulfikri Nurhan, Winda Fatma Sari, Chrismawan Ardianto, and Junaidi Khotib
Veterinary World, 15(9): 2333-2341

Yusuf Alif Pratama: Master Program of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
Fakhriyah Dinina: Bachelor Program of Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
Ahmad Dzulfikri Nurhan: Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
Winda Fatma Sari: Bachelor Program of Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
Chrismawan Ardianto: Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
Junaidi Khotib: Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.

doi: www.doi.org/10.14202/vetworld.2022.2333-2341

Share this article on [Facebook] [LinkedIn]

Article history: Received: 27-05-2022, Accepted: 26-08-2022, Published online: 29-09-2022

Corresponding author: Junaidi Khotib

E-mail: junaidi-k@ff.unair.ac.id

Citation: Pratama YA, Dinina F, Nurhan AD, Sari WF, Ardianto C, and Khotib J (2022) Effectiveness of Indonesian house dust mite allergenic extract in triggering allergic rhinitis sensitivity in a mouse model: A preliminary study, Veterinary World, 15(9): 2333–2341.
Abstract

Background and Aim: Perennial allergic rhinitis (AR) is a chronic upper respiratory disease, with inflammation mediated by immunoglobulin E in the nasal mucosa caused by house dust mites. Recently, allergen immunotherapy showed promising allergic healing in patients with a definite history of sensitization. Based on this finding, a product was developed using Indonesian house dust mite (IHDM). This study aimed to optimize the allergenic rhinitis mouse model that was generated using IHDM to test the in vivo sensitivity and safety of this product.

Materials and Methods: Seven groups of mice were used for effectiveness testing – normal, negative control with IHDM challenge, positive control with 0.1% histamine challenge, and AR group by both IHDM-induced sensitization at 12.5, 50, 250, or 500 μg and IHDM challenge. Mice were sensitized by intraperitoneal administration of IHDM once a week for 3 consecutive weeks. Thereafter, the challenge was given intranasally 5 times on alternate days. The number of nose rubbing and sneezing was noted. Eosinophil infiltration was assessed histologically using hematoxylin and eosin staining. The expression of interleukin-5 (IL-5) mRNA in the nasal mucosa was determined using semi-quantitative reverse transcription-polymerase chain reaction.

Results: The induction of AR with IHDM significantly increased the number of nose rubbing and sneezing in the mouse model. Eosinophil infiltration was observed in the nasal mucosa; however, no significant change occurred in the expression of IL-5 mRNA.

Conclusion: Overall, these data indicate that IHDM allergenic extract could be an effective sensitizing agent in a mouse model of AR. Although the use of IHDM is a limitation of this study because other sources of house dust mites might have different effects, this study provides a proper model for immunotherapy effectivity testing for in vivo pre-clinical studies.

Keywords: allergen immunotherapy, allergic healing, allergic rhinitis, Indonesian house dust mites, neglected disease.